Cambridge Healthtech Institute’s 7th Annual

Characterization of Biotherapeutics

January 19-20, 2021

 

The popular 7th Annual Characterization of Biotherapeutics conference will bring together leading scientists from the biopharmaceutical industry, academia and government to discuss case studies, new technologies, assay on analytical development and characterization of mAbs, ADCs, bispecifics, and other novel protein formats. Some of the hot topics for discussion this year will include developability of new product formats, cell and gene therapy products, biosimilars, high-throughput analytics, multi attribute methods, glycosylation/post-translational modifications, biophysical assays and more.

 

We invite you to submit a proposal, present a poster and attend to join with colleagues in this discussion of the key challenges and solutions improving predication, screening and characterization of new biologics.

 

Coverage will include, but is not limited to:                              

  • Developability and analytical characterization and new assay:
    • Antibody-drug conjugates (ADCs), bispecifics, multi-specifics, fusion proteins fusion proteins oligos, new protein formats and new viral therapeutics
    • Cell and gene therapy products
    • Biosimilars and analytical comparability
    • Characterization of conjugation
  • Structure, function and stability relationship:
    • Higher order structure (HOS) characterization in biologics
    • Glycosylation/post-translational modifications
    • Protein conformation
    • Determining CQA and acceptance criteria
    • Pharmacology and in vivo characterization
    • Biophysical characterization and property-based molecular design
  • Analytics:
    • Mass spectroscopy
    • New tools for sequence variance analysis and multi-attribute analysis
    • High-throughput assays, automation, in-line assays and miniaturized assay
    • Characterization of process impurities, product variants, post translational modifications
    • Biodistribution and in vivo fate of biologics: case studies on correlation between in vitro and in vivo findings     

 

If you would like to submit a proposal to give a presentation at this meeting, please click here.

 

The deadline for priority consideration is July 24, 2020.

 

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

If you are selected as a speaker for this virtual event, we request that you pre-record your presentation and be available during the “live” portion January 19-20 for interactive Q&A and panel discussions.  

 

 

For more details on the conference, please contact:

Nandini Kashyap, MPharm

Conference Director

Cambridge Healthtech Institute

Phone: (+1) 781-972-5406 Email: nkashyap@healthtech.com

 

For partnering and sponsorship information, please contact:

Companies A-K

Jason Gerardi

Senior Manager, Business Development

Cambridge Healthtech Institute

Phone: (+1) 781-972-5452 Email: jgerardi@healthtech.com

 

Companies L-Z

Ashley Parsons

Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-1340 Email: ashleyparsons@healthtech.com